These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37551494)

  • 1. [Human Umbilical Cord-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation Via Exosome-Mediated MicroRNA and Its Mechanism].
    Luo YM; Zhong JY; Jian XY; Zhang LY; Zhang L; Ding Y; Ma YH; Chen YY; Lin QR; Qi ZQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1171-1178. PubMed ID: 37551494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes Released From Human Bone Marrow-Derived Mesenchymal Stem Cell Attenuate Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Mice.
    Li KL; Li JY; Xie GL; Ma XY
    Front Cell Dev Biol; 2021; 9():617589. PubMed ID: 33889570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells.
    Liu W; Zhou N; Liu Y; Zhang W; Li X; Wang Y; Zheng R; Zhang Y
    Stem Cell Res Ther; 2021 Feb; 12(1):153. PubMed ID: 33637123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice.
    Wu SCM; Zhu M; Chik SCC; Kwok M; Javed A; Law L; Chan S; Boheler KR; Liu YP; Chan GCF; Poon EN
    Stem Cell Res Ther; 2023 Jun; 14(1):167. PubMed ID: 37357314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
    Zhao L; Chen S; Yang P; Cao H; Li L
    Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.
    Si Y; Yang K; Qin M; Zhang C; Du Z; Zhang X; Liu Y; Yue Y; Feng Z
    Pediatr Hematol Oncol; 2014 Feb; 31(1):39-49. PubMed ID: 24383400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Keklik M; Deveci B; Celik S; Deniz K; Gonen ZB; Zararsiz G; Saba R; Akyol G; Ozkul Y; Kaynar L; Keklik E; Unal A; Cetin M; Jones OY
    Ann Hematol; 2023 Jun; 102(6):1537-1547. PubMed ID: 37067556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord-derived mesenchymal stem cells promote myeloid-derived suppressor cell enrichment by secreting CXCL1 to prevent graft-versus-host disease after hematopoietic stem cell transplantation.
    Wang R; Wang X; Yang S; Xiao Y; Jia Y; Zhong J; Gao Q; Zhang X
    Cytotherapy; 2021 Nov; 23(11):996-1006. PubMed ID: 34465514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
    Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
    Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.
    Fang S; Xu C; Zhang Y; Xue C; Yang C; Bi H; Qian X; Wu M; Ji K; Zhao Y; Wang Y; Liu H; Xing X
    Stem Cells Transl Med; 2016 Oct; 5(10):1425-1439. PubMed ID: 27388239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
    Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
    Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel study on the immunomodulatory effect of umbilical cord derived mesenchymal stem cells pretreated with traditional Chinese medicine Asarinin.
    He H; Yang T; Li F; Zhang L; Ling X
    Int Immunopharmacol; 2021 Nov; 100():108054. PubMed ID: 34492537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Curative effect of human umbilical cord mesenchymal stem cells for treatment of acute graft-versus-host disease of children after allo-HSCT].
    Qiao SM; Chen GH; Wang Y; Hu SY; Sun XD; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):716-20. PubMed ID: 23815929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell-derived exosomes for managing graft-versus-host disease: An updated view.
    Shafeghat Z; Dorfaki M; Dehrouyeh S; Arab FL; Roozbehani M; Falak R; Faraji F; Jafari R
    Transpl Immunol; 2023 Dec; 81():101957. PubMed ID: 37935319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Co-transplantation of Hematopoietic Stem Cells Combined With Human Umbilical Cord-Derived Mesenchymal Stem Cells in Children With Severe Aplastic Anemia: A Single-Center Experience.
    Akçay A; Atay D; Erbey F; Akıncı B; Demir Yenigürbüz F; Eyüboğlu F; Ovalı E; Öztürk G
    Exp Clin Transplant; 2022 Dec; 20(12):1114-1121. PubMed ID: 34142939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor stimulates exosomal microRNA-21 derived from mesenchymal stem cells to ameliorate aGVHD by modulating regulatory T cells.
    Zhu H; Lan L; Zhang Y; Chen Q; Zeng Y; Luo X; Ren J; Chen S; Xiao M; Lin K; Chen M; Li Q; Chen Y; Xu J; Zheng Z; Chen Z; Xie Y; Hu J; Yang T
    FASEB J; 2020 Jun; 34(6):7372-7386. PubMed ID: 32314840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.